Andreas Wagner sells ALHC shares under Rule 144 (ALHC)
Rhea-AI Filing Summary
Alignment Healthcare reported Rule 144 sale notices covering transactions by Andreas Wagner and planned dispositions of vested restricted stock units. The filing lists two recent sales: 21,118 shares sold on 03/04/2026 for $393,250.95 and 22,238 shares sold on 02/10/2026 for $455,211.86.
The filing also lists vested restricted stock units acquired on 03/13/2024 (15,000 shares) and 03/13/2025 (8,602 shares) that are described as securities to be sold.
Positive
- None.
Negative
- None.
Insights
Rule 144 notices document reported sales and list vested RSUs that may be sold.
These entries show two completed dispositions by Andreas Wagner totaling $848,462.81 in proceeds across 02/10/2026 and 03/04/2026, using a Rule 10b5-1 plan for at least one trade as stated.
Separately, the form lists 15,000 and 8,602 shares acquired from RSU vesting on 03/13/2024 and 03/13/2025; these entries identify shares that are eligible for sale under Rule 144 but do not specify timing or distribution method.
FAQ
What insider sales did Alignment Healthcare (ALHC) disclose?
Which vested equity holdings are listed for potential sale in the ALHC filing?
Were any sales reported as part of a 10b5-1 plan in the ALHC Form 144?
How much aggregate proceeds are shown from the disclosed sales?
Does the filing specify timing or method for selling the vested RSU shares?